APA (7th ed.) Citation

Oldenburg, J., Hay, C., Peyvandi, F., Lehtinen, A., Pabinger, I., Nüesch, E., . . . Lethagen, S. (2025). A-SURE: Intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia A. Hematology, 30(1), 1. https://doi.org/10.1080/16078454.2025.2513186

Chicago Style (17th ed.) Citation

Oldenburg, Johannes, Charles Hay, Flora Peyvandi, Anna-Elina Lehtinen, Ingrid Pabinger, Eveline Nüesch, Håkan Malmström, Eva Bednar, and Stefan Lethagen. "A-SURE: Intra-patient Comparison of Prophylactic Effectiveness of a Recombinant Factor VIII Fc Fusion Protein Versus Standard Half-life Factor VIII in Hemophilia A." Hematology 30, no. 1 (2025): 1. https://doi.org/10.1080/16078454.2025.2513186.

MLA (9th ed.) Citation

Oldenburg, Johannes, et al. "A-SURE: Intra-patient Comparison of Prophylactic Effectiveness of a Recombinant Factor VIII Fc Fusion Protein Versus Standard Half-life Factor VIII in Hemophilia A." Hematology, vol. 30, no. 1, 2025, p. 1, https://doi.org/10.1080/16078454.2025.2513186.